Operating Income (Loss) in USD of Biofrontera Inc. from Q3 2020 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Biofrontera Inc. quarterly/annual Operating Income (Loss) history and change rate from Q3 2020 to Q3 2025.
  • Biofrontera Inc. Operating Income (Loss) for the quarter ending September 30, 2025 was -$6.28M, a 26.6% decline year-over-year.
  • Biofrontera Inc. Operating Income (Loss) for the twelve months ending September 30, 2025 was -$17.6M, a 9.03% increase year-over-year.
  • Biofrontera Inc. annual Operating Income (Loss) for 2024 was -$17.2M, a 24.1% increase from 2023.
  • Biofrontera Inc. annual Operating Income (Loss) for 2023 was -$22.7M, a 22% decline from 2022.
  • Biofrontera Inc. annual Operating Income (Loss) for 2022 was -$18.6M, a 26.3% increase from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

Biofrontera Inc. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$17.6M -$6.28M -$1.32M -26.6% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-12
Q2 2025 -$16.3M -$5.08M -$8K -0.16% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-13
Q1 2025 -$16.3M -$4.55M +$920K +16.8% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-15
Q4 2024 -$17.2M -$1.71M +$2.15M +55.7% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-20
Q3 2024 -$19.4M -$4.96M -$340K -7.36% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-12
Q2 2024 -$19M -$5.07M +$3.63M +41.7% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-13
Q1 2024 -$22.7M -$5.47M +$25K +0.46% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-15
Q4 2023 -$22.7M -$3.87M +$1.75M +31.2% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-20
Q3 2023 -$24.4M -$4.62M -$981K -27% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$23.5M -$8.7M -$2.49M -40% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$21M -$5.49M -$2.38M -76.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$18.6M -$5.62M -$3.74M -199% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-15
Q3 2022 -$14.8M -$3.64M +$12.5M +77.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$27.3M -$6.21M -$2.53M -68.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 -$24.8M -$3.11M +$418K +11.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 -$25.2M -$1.88M Oct 1, 2021 Dec 31, 2021 8-K 2023-10-03
Q3 2021 -$16.1M -$13.8M -587% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$3.69M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 -$3.53M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q3 2020 -$2.34M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-30

Biofrontera Inc. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$17.2M +$5.47M +24.1% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-20
2023 -$22.7M -$4.1M -22% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-20
2022 -$18.6M +$6.62M +26.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-15
2021 -$25.2M -$15.6M -162% Jan 1, 2021 Dec 31, 2021 8-K 2023-10-03
2020 -$9.61M Jan 1, 2020 Dec 31, 2020 10-K 2022-04-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.